Skip to main content
. 2020 Oct 17;72(8):431–437. doi: 10.1007/s00251-020-01179-1

Fig. 1.

Fig. 1

Forest plot with pooled effects and 95% confidence interval (CI) indicating the association between interleukin-6 (IL-6) level and adverse outcomes in coronavirus disease 2019 patients (a). Subgroup analysis based on different disease outcomes (severe (b), ICU (intensive care unit) admission (c), death (d)). Sensitivity analysis (e).